Celsius Holdings, Inc. (NASDAQ:CELH) HOLD
Celsius is the functional-energy challenger — CELSIUS plus the Alani Nu and Rockstar brands hold north of 20% of the US energy category, distributed through PepsiCo. Quality is a fair 66 and the valuation is attractive: the $42 base case is about 21x FY27 earnings, ~43% above spot. The medium and long calls are a BUY; the short call is HOLD because the tape has broken down into a strong downtrend.
Re-presenting the Donatien Investment report on Celsius Holdings (NASDAQ:CELH), dated 20 July 2026, at US$29.42. Short-term HOLD; medium- and long-term BUY.
The functional-energy challenger
Celsius Holdings makes CELSIUS, a better-for-you energy drink pitched at health-conscious, younger consumers as an alternative to the sugary incumbents. Through its 2025 acquisitions of Alani Nu and PepsiCo's Rockstar it has built a multi-brand portfolio that together commands more than twenty per cent of the fast-growing US energy-drink category — second only to the Red Bull and Monster duopoly. Its defining strategic asset is a distribution partnership with PepsiCo, which puts its cans in front of the whole country. Business quality is a fair sixty-six: a real brand with a real runway, but in a genuinely intensifying field.
Cheap on a real growth runway
The valuation is what makes the longer horizons a buy. The base case of forty-two dollars is about twenty-one times FY27 earnings of roughly one dollar ninety-eight — near the base analyst view and some forty-three per cent above the current price, against a warranted multiple of about twenty-three times. The valuation pillar scores sixty-five. Consensus sits at forty-nine sixty-seven, with a high of fifty-seven. So the medium and long calls are a buy: a share-gaining challenger on a real growth runway at a fair-to-attractive price, provided the organic scanner data holds up.
Short HOLD: the tape broke down
So why hold for the short term? The tape. Timing has deteriorated from basing near support to a strong downtrend with a support breakdown, and the timing pillar sits at forty-six. On top of that is a Texas Attorney-General and Pomerantz legal overhang that has just emerged. That is a reason to wait for the chart and the news to settle, not to sell the thesis. The bear case is near twenty-five dollars, where competition from Ghost, KDP and Monster, weight-loss drugs capping volumes, promotional pressure and a deepening legal overhang would roll organic share over — the thesis-invalidation trigger.
What could go wrong
Intensifying field: Monster, Ghost/KDP press hard. GLP-1 drugs + promo pressure on volumes/margin. Legal overhang; bear ~$25 if share rolls over.
Risk vs Reward
Against the current US$29.42, the report frames a bull case at US$51 (+73%), a base case at US$42 (+43%) and a bear case at US$25 (-15%). See the full report for the probability weight behind each path.
The verdict
Celsius is the functional-energy challenger — CELSIUS plus the Alani Nu and Rockstar brands hold north of 20% of the US energy category, distributed through PepsiCo. Quality is a fair 66 and the valuation is attractive: the $42 base case is about 21x FY27 earnings, ~43% above spot. The medium and long calls are a BUY; the short call is HOLD because the tape has broken down into a strong downtrend.
Read the full report on donatien.ca →
